Ginkgo Bioworks reported Q4 revenues down 24% year-over-year and missing estimates by over $4 million. Read why I rate DNA ...

Ginkgo Bioworks Holdings, Inc. (DNA) shares rallied 18.9% in the last trading session to close at $11.25. This move can be attributable to notable volume with a higher number of shares being traded ...

The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $10.88 / share. This is a decrease of 11.11% from the prior estimate of $12.24 dated November 7, 2025. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Shares of Ginkgo Bioworks fell after the company reported lower fourth-quarter revenue and said it would sell its biosecurity business in exchange for a minority equity position in the business. The ...

We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings (NYSE: DNA) shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University under the Advanced ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.00 in the latest trading session, marking a -3.12% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.1%. On the ...